Marangoni-Iglecias, L.M.; Sánchez-Martin, A.; Pineda-Lancheros, L.E.; Cura, Y.; Marquez-Pete, N.; Gálvez-Navas, J.M.; Báez-Gutiérrez, N.; Jara-Vera, A.M.d.L.; Urrutia-Maldonado, E.; Pérez-Ramírez, C.;
et al. Impact of Pharmacogenetics on High-Dose Methotrexate Toxicity in Pediatric Oncology. Pharmaceutics 2025, 17, 585.
https://doi.org/10.3390/pharmaceutics17050585
AMA Style
Marangoni-Iglecias LM, Sánchez-Martin A, Pineda-Lancheros LE, Cura Y, Marquez-Pete N, Gálvez-Navas JM, Báez-Gutiérrez N, Jara-Vera AMdL, Urrutia-Maldonado E, Pérez-Ramírez C,
et al. Impact of Pharmacogenetics on High-Dose Methotrexate Toxicity in Pediatric Oncology. Pharmaceutics. 2025; 17(5):585.
https://doi.org/10.3390/pharmaceutics17050585
Chicago/Turabian Style
Marangoni-Iglecias, Luciana Maria, Almudena Sánchez-Martin, Laura Elena Pineda-Lancheros, Yasmín Cura, Noelia Marquez-Pete, José María Gálvez-Navas, Nerea Báez-Gutiérrez, Adrián Manuel de La Jara-Vera, Emilia Urrutia-Maldonado, Cristina Pérez-Ramírez,
and et al. 2025. "Impact of Pharmacogenetics on High-Dose Methotrexate Toxicity in Pediatric Oncology" Pharmaceutics 17, no. 5: 585.
https://doi.org/10.3390/pharmaceutics17050585
APA Style
Marangoni-Iglecias, L. M., Sánchez-Martin, A., Pineda-Lancheros, L. E., Cura, Y., Marquez-Pete, N., Gálvez-Navas, J. M., Báez-Gutiérrez, N., Jara-Vera, A. M. d. L., Urrutia-Maldonado, E., Pérez-Ramírez, C., & Jiménez-Morales, A.
(2025). Impact of Pharmacogenetics on High-Dose Methotrexate Toxicity in Pediatric Oncology. Pharmaceutics, 17(5), 585.
https://doi.org/10.3390/pharmaceutics17050585